Retrospective evaluation of referral by community health workers on the uptake of intermittent preventive treatment of Malaria in pregnancy in Ohaukwu, Ebonyi State, Nigeria.
Antimalarials
/ therapeutic use
Community Health Workers
Drug Combinations
Female
Humans
Malaria
/ drug therapy
Nigeria
Pregnancy
Pregnancy Complications, Parasitic
/ prevention & control
Prenatal Care
Pyrimethamine
/ therapeutic use
Referral and Consultation
Retrospective Studies
Sulfadoxine
/ therapeutic use
Antenatal care
Community distribution
Intermittent preventive treatment
Malaria
Pregnancy
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
27 Jul 2022
27 Jul 2022
Historique:
received:
07
03
2022
accepted:
12
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
30
7
2022
Statut:
epublish
Résumé
The World Health Organization recommends a minimum of three doses of quality-assured sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy (IPTp), in moderate to high malaria transmission areas in sub-Saharan Africa. Currently, coverage of IPTp lags behind coverage of antenatal care (ANC) visits; in Nigeria, 57% of women attended four or more ANC visits, whereas only 17% received the recommended three or more doses of IPTp. The innovative program aimed to close this gap by providing counseling on the benefits of comprehensive ANC, referral to ANC and community distribution of IPTp (C-IPTp), complementing IPTp at ANC. The study aimed to examine whether CHW referral to ANC improved the likelihood of receiving three or more doses of IPTp. The data for this study were extracted from the maternity record books of 1437 pregnant women seen at 25 public health facilities in Ebonyi State, Nigeria. The outcome of interest was defined as the receipt of three or more doses of IPTp (IPTp3) and the independent variable was referral to ANC by a community health worker for any visit. Descriptive statistics were reported and the results from the multi-level regressions are reported as adjusted odds and prevalence ratios with corresponding 95% confidence intervals. Of the 936 women included in the analysis, 24.47% received the recommended three or more IPTp doses and 61.32% were referred by a community health worker (CHW) for at least one ANC visit. There was no difference in the mean number of ANC visits between women who received C-IPTp and those who received IPTp exclusively at a facility (2.40 vs 2.52; p = 0.374). There were no maternal characteristics associated with CHW referral. Women who were referred by a CHW had 60% greater odds (95% CI, 1.08-2.38) of receiving IPTp3 than those who were never referred. The results indicate that CHW referrals conducted within a C-IPTp program are associated with higher IPTp uptake but not fewer ANC visits and that CHWs applied the referral process equally. This strengthens the evidence base for C-IPTp scale-up, which could have a large impact in sub-Saharan Africa in mitigating existing health systems issues.
Sections du résumé
BACKGROUND
BACKGROUND
The World Health Organization recommends a minimum of three doses of quality-assured sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy (IPTp), in moderate to high malaria transmission areas in sub-Saharan Africa. Currently, coverage of IPTp lags behind coverage of antenatal care (ANC) visits; in Nigeria, 57% of women attended four or more ANC visits, whereas only 17% received the recommended three or more doses of IPTp. The innovative program aimed to close this gap by providing counseling on the benefits of comprehensive ANC, referral to ANC and community distribution of IPTp (C-IPTp), complementing IPTp at ANC. The study aimed to examine whether CHW referral to ANC improved the likelihood of receiving three or more doses of IPTp.
METHODS
METHODS
The data for this study were extracted from the maternity record books of 1437 pregnant women seen at 25 public health facilities in Ebonyi State, Nigeria. The outcome of interest was defined as the receipt of three or more doses of IPTp (IPTp3) and the independent variable was referral to ANC by a community health worker for any visit. Descriptive statistics were reported and the results from the multi-level regressions are reported as adjusted odds and prevalence ratios with corresponding 95% confidence intervals.
RESULTS
RESULTS
Of the 936 women included in the analysis, 24.47% received the recommended three or more IPTp doses and 61.32% were referred by a community health worker (CHW) for at least one ANC visit. There was no difference in the mean number of ANC visits between women who received C-IPTp and those who received IPTp exclusively at a facility (2.40 vs 2.52; p = 0.374). There were no maternal characteristics associated with CHW referral. Women who were referred by a CHW had 60% greater odds (95% CI, 1.08-2.38) of receiving IPTp3 than those who were never referred.
CONCLUSION
CONCLUSIONS
The results indicate that CHW referrals conducted within a C-IPTp program are associated with higher IPTp uptake but not fewer ANC visits and that CHWs applied the referral process equally. This strengthens the evidence base for C-IPTp scale-up, which could have a large impact in sub-Saharan Africa in mitigating existing health systems issues.
Identifiants
pubmed: 35896992
doi: 10.1186/s12884-022-04921-7
pii: 10.1186/s12884-022-04921-7
pmc: PMC9327266
doi:
Substances chimiques
Antimalarials
0
Drug Combinations
0
Sulfadoxine
88463U4SM5
Pyrimethamine
Z3614QOX8W
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
599Informations de copyright
© 2022. The Author(s).
Références
Malar J. 2021 Jun 23;20(1):277
pubmed: 34162384
Malar J. 2016 Nov 4;15(1):533
pubmed: 27814763
PLoS Med. 2013;10(7):e1001488
pubmed: 23935459
Malar J. 2011 Aug 05;10:227
pubmed: 21819579
Malar J. 2018 May 25;17(1):211
pubmed: 29793482
Lancet. 2007 Jun 23;369(9579):2121-31
pubmed: 17586307
Trop Med Int Health. 2009 Feb;14(2):183-9
pubmed: 19207178
Malar J. 2013 Sep 23;12:342
pubmed: 24059757
Trop Med Infect Dis. 2018 Feb 11;3(1):
pubmed: 30274416
Reprod Health. 2012 Aug 13;9:12
pubmed: 22889320
Res Social Adm Pharm. 2017 Jul - Aug;13(4):875-879
pubmed: 27816564
Int J Epidemiol. 2021 May 17;50(2):550-559
pubmed: 33349871
Arch Public Health. 2021 Oct 21;79(1):182
pubmed: 34670628
Malar J. 2013 Oct 03;12:353
pubmed: 24090252
Malar J. 2014 Jan 14;13:22
pubmed: 24423279
BMC Public Health. 2013 Sep 13;13:847
pubmed: 24034792
Malar J. 2020 Aug 5;19(1):282
pubmed: 32758233
Malar J. 2014 Nov 20;13:440
pubmed: 25409680
PLoS Med. 2011 Feb 01;8(2):e1000409
pubmed: 21304921
Matern Child Health J. 2022 Jan;26(1):79-101
pubmed: 34981332